Nihat Şen
Impact in
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Cardiac Arrhythmias and Treatments 6
- Cardiovascular Disease and Adiposity 5
- Atrial Fibrillation Management and Outcomes 5
- Oncology 13
- Inflammatory Biomarkers in Disease Prognosis 13
- Co-authors
- Yusuf Tavıl (26 shared papers)Atiye Çengel (17 shared papers)Adnan Burak Akçay (30 shared papers)Mustafa Kurt (27 shared papers)Eyüp Büyükkaya (26 shared papers)M.F. Karakaş (26 shared papers)Adnan Abacı (9 shared papers)Esra Karakaş (9 shared papers)
- Journals
- Coronary Artery Disease (5 papers)Journal of Investigative Medicine (5 papers)Clinical and investigative medicine (4 papers)Atherosclerosis (4 papers)Journal of the American College of Cardiology (2 papers)
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Nihat Şen
80 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 108
- Nephrology 200
- Internal Medicine 75
- Cardiology and Cardiovascular Medicine 432
- Oncology 486
- Immunology 160
Countries citing papers authored by Nihat Şen
This map shows the geographic impact of Nihat Şen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nihat Şen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nihat Şen more than expected).
Fields of papers citing papers by Nihat Şen
This network shows the impact of papers produced by Nihat Şen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nihat Şen. The network helps show where Nihat Şen may publish in the future.
Co-authors
The 25 scholars most cited alongside Nihat Şen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 169 | |
| 2 | 2006 | 145 | |
| 3 | 2013 | 124 | |
| 4 | 2013 | 116 | |
| 5 | 2007 | 82 | |
| 6 | 2013 | 75 | |
| 7 | 2012 | 59 | |
| 8 | 2010 | 48 | |
| 9 | 2006 | 40 | |
| 10 | 2010 | 35 | |
| 11 | 2013 | 34 | |
| 12 | 2013 | 34 | |
| 13 | 2011 | 33 | |
| 14 | 2007 | 33 | |
| 15 | 2012 | 32 | |
| 16 | 2009 | 31 | |
| 17 | Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. | 2009 | 30 |
| 18 | 2011 | 29 | |
| 19 | 2009 | 28 | |
| 20 | 2013 | 25 |
About Nihat Şen
Nihat Şen is a scholar working on Cardiology and Cardiovascular Medicine, Oncology, Surgery, Molecular Biology and Nephrology, having authored 86 papers that have together received 1.7k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (13 papers), Cardiac Arrhythmias and Treatments (6 papers), Gout, Hyperuricemia, Uric Acid (5 papers), Cardiovascular Disease and Adiposity (5 papers), Inflammasome and immune disorders (5 papers), Atrial Fibrillation Management and Outcomes (5 papers), Biomarkers in Disease Mechanisms (4 papers) and Coronary Interventions and Diagnostics (4 papers). The work is most often cited by research in Nephrology (200 citations), Internal Medicine (75 citations), Cardiology and Cardiovascular Medicine (432 citations), Oncology (486 citations) and Immunology (160 citations). Nihat Şen has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Yusuf Tavıl, Atiye Çengel, Adnan Burak Akçay, Mustafa Kurt, Eyüp Büyükkaya, M.F. Karakaş, Adnan Abacı, Esra Karakaş, İbrahi̇m Hali̇l Tanboğa and Fırat Özcan. Their work appears in journals such as Coronary Artery Disease, Journal of Investigative Medicine, Clinical and investigative medicine, Atherosclerosis and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.